Finland Archives - MEDIC NEST

FinlandMedaffcon

January 27, 2023by pcdata

Type: Research Project page: Access page Country: Finland Synopsis: Medaffcon provides research and expert services for the needs of the pharmaceutical industry and healthcare professionals. Our activities are characterized by wide-ranging expertise, solid cooperation networks and the development of innovative solutions. Our experts have held various positions in the pharmaceutical industry and healthcare, research and...

FinlandFiMM – Institute for Molecular Medicine Finland

January 27, 2023by pcdata

Type: Research Project page: Access page Country: Finland Synopsis: FIMM is a translational research institute focusing on human genomics and personalized medicine at the Helsinki Institute for Life Science of the University of Helsinki. FIMM has a driving mission to perform innovative research on patients and populations targeted towards understanding drivers of health and disease...

FinlandUniversity of Helsinki – Precision Systems Medicine

January 27, 2023by pcdata

Type: Research Project page: Access page Country: Finland Synopsis: We would need to achieve a much better and comprehensive molecular understanding of the complexity of cancer in individual patients, across the spatial dimension of tumor tissues as well over time. We believe that better prediction of cancer drug efficacies would improve and personalize patient care,...

Belgium Finland France Italy Netherlands Slovenia Spain Sweden SwitzerlandRISK-BASED SCREENING FOR CERVICAL CANCER

July 19, 2022by pcdata

Dates: 01/10/2020 31/12/2024 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Cervical Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: STICHTING VUMC Keywords: screening; cervical cancer; tumour; HPV; cytology; DNA; e-health; vaccine; clinical trial Countries: Netherlands; Sweden; France; Finland; Spain; Belgium; Slovenia;...

Belgium Finland France Germany Latvia Spain UK USAToward Precision Toxicology: New Approach Methodologies for Chemical Safety

July 19, 2022by pcdata

Dates: 01/02/2021 31/01/2026 Topic: Biomarkers identification Procedures Project type: Preclinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5. – Methods and data Participating agents: THE UNIVERSITY OF BIRMINGHAM Keywords: biomark; animal model; mammology; machine learning; toxicology; procedures; chemical Countries: UK; Germany; Spain; USA; France; Belgium; Finland; Latvia Project...

Cyprus Denmark Finland IrelandA Personalised Living Cell Synthetic Computing Circuit for Sensing and Treating Neurodegenerative Disorders

July 19, 2022by pcdata

Dates: 01/02/2021 31/01/2025 Topic: Tool Project type: Medical Device Project target: Neurology Financing: H2020-EU.1.2. – EXCELLENT SCIENCE – Future and Emerging Technologies (FET) H2020-EU.1.2.1. – FET Open Participating agents: WATERFORD INSTITUTE OF TECHNOLOGY Keywords: RNA; epilepsy; AI; implant; therapeutic; tRNA; neurology; computer cells Countries: Ireland; Denmark; Cyprus; Finland Project page: Access page

Finland Ireland Italy Latvia Portugal Serbia SwitzerlandPrecision medicine for muscoloskeletal regeneration; prosthetics and active ageing

July 19, 2022by pcdata

Dates: 01/01/2020 30/09/2024 Topic: Procedures Project type: Medical Device Project target: Other Financing: H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions H2020-EU.1.3.1. – Fostering new skills by means of excellent initial training of researchers Participating agents: UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO -AALTO KORKEAKOULUSAATIO SR -AO-FORSCHUNGSINSTITUT DAVOS -RIGAS TEHNISKA UNIVERSITATE -FACULTY OF TECHNOLOGY...

Austria Denmark Finland France Germany Italy Netherlands Sweden Switzerland UK USABiomarker Enterprise to Attack Diabetes Kidney Disease

July 19, 2022by pcdata

Dates: 01/09/2016 31/08/2023 Topic: Biomarkers identification Project type: Preclinic Project target: Endocrine disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: LUNDS UNIVERSITET -HELSINGIN YLIOPISTO -ACADEMISCH ZIEKENHUIS GRONINGEN -ITA-SUOMEN YLIOPISTO -UNIVERSITY OF DUNDEE -THE UNIVERSITY OF EXETER -Istituto di Ricerche Farmacologiche Mario...